Info

JDS Pharmaceuticals is a specialty pharmaceutical company dedicated to improving the lives of people suffering from psychiatric illness. We identify, develop and deliver safe medicines so that people with depression and bipolar disorder can measurably improve their quality of life. To do this, we draw on the expertise of our clinical and management leadership as well as on our strategic alliances with the psychiatric community. JDS markets two CNS products: Pexeva® for major depressive disorder, panic disorder (PD), obsessive compulsive disorder (OCD) and Lithobid® for bipolar disorder. Our R&D pipeline is guided by world-renowned experts in psychiatry.